FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Clozapine filed by Mylan Pharmaceuticals Inc., enabling continued generic availability under ANDA201824.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)